AI Summary
We reviewed 7 live results for interferon and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Interferon and Immunostimulant.
Comparison Table
Recommended
Avonex (Interferon beta-1a)
Source: Biogen Inc.
Description
Avonex is an interferon-based immunostimulant therapy indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps manage relapsing-remitting disease and clinically isolated syndrome by modulating the immune response to reduce inflammation and lesion formation.
Best for
multiple sclerosis patients, MS relapse management, clinically isolated syndrome and adult immune therapy
View Details
Rating
Besremi
Source: PharmaEssentia
Description
Besremi (ropeginterferon alfa-2b) is a solution for injection provided in a 500 mcg/mL pre-filled syringe. It is a monopegylated interferon specifically indicated for the treatment of adults with Polycythemia Vera (PV). It was recently registered by the Health Sciences Authority (HSA) in May 2024 and launched in Singapore in September 2024 as a new long-acting interferon option.
Best for
Polycythemia Vera patients, long-acting interferon therapy, newly registered HSA treatments and hematology patients
View Details
Rating
Pegasys
Source: Roche
Description
Pegasys is a peginterferon alfa-2a medication available as a solution for injection in pre-filled syringes (135 mcg/0.5 mL or 180 mcg/0.5 mL). It is primarily indicated for the treatment of chronic hepatitis B and hepatitis C infections. This long-acting interferon therapy is listed in Singapore's National Drug Formulary (NDF) and is stocked across major public healthcare institutions such as SGH, NUH, and TTSH.
Best for
chronic hepatitis B treatment, chronic hepatitis C management, patients seeking formulary drugs and hospital-based therapy
View Details
Rating
| Compare | Avonex (Interferon beta-1a) | Besremi | Pegasys |
|---|---|---|---|
| Source | Biogen Inc. | PharmaEssentia | Roche |
| Description | Avonex is an interferon-based immunostimulant therapy indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps manage relapsing-remitting disease and clinically isolated syndrome by modulating the immune response to reduce inflammation and lesion formation. | Besremi (ropeginterferon alfa-2b) is a solution for injection provided in a 500 mcg/mL pre-filled syringe. It is a monopegylated interferon specifically indicated for the treatment of adults with Polycythemia Vera (PV). It was recently registered by the Health Sciences Authority (HSA) in May 2024 and launched in Singapore in September 2024 as a new long-acting interferon option. | Pegasys is a peginterferon alfa-2a medication available as a solution for injection in pre-filled syringes (135 mcg/0.5 mL or 180 mcg/0.5 mL). It is primarily indicated for the treatment of chronic hepatitis B and hepatitis C infections. This long-acting interferon therapy is listed in Singapore's National Drug Formulary (NDF) and is stocked across major public healthcare institutions such as SGH, NUH, and TTSH. |
| Best for | multiple sclerosis patients, MS relapse management, clinically isolated syndrome and adult immune therapy | Polycythemia Vera patients, long-acting interferon therapy, newly registered HSA treatments and hematology patients | chronic hepatitis B treatment, chronic hepatitis C management, patients seeking formulary drugs and hospital-based therapy |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Avonex (Interferon beta-1a) from Biogen Inc.."
I picked this because Avonex is a well-established interferon therapy used to manage the immune response in patients with relapsing multiple sclerosis.
Share this search
Related Finds